Mateusz Rybka

Mr. Mateusz Rybka

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 November 2021 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
Marek KonopMarek Konop
Marek Konop
MRMateusz Rybka
Mateusz Rybka
ADAdrian Drapala
Adrian Drapala
Impaired wound healing is a major medical problem. To solve it, researchers around the world have turned their attention to the use of tissue-engineered products to aid in skin regeneration in case of acute and chronic wounds. One of the primary goals of tissue engineering and regenerative medicine is to develop a matrix or scaffold system that mimics the structure and function of native tissue. Keratin biomaterials derived from wool, hair, and bristle have been the subjects of active research in the context of tissue regeneration for over a decade. Keratin derivatives, which can be either soluble or insoluble, are utilized as wound dressings since keratins are dynamically up-regulated and needed in skin wound healing. Tissue biocompatibility, biodegradability, mechanical durability, and natural abundance are only a few of the keratin biomaterials’ properties, making them excellent wound dressing materials to treat acute and chronic wounds. Several experimental and pre-clinical studies described the beneficial effects of the keratin-based wound dressing in faster wound healing. This review focuses exclusively on the biomedical application of a different type of keratin biomaterials as a wound dressing in pre-clinical and clinical conditions.

27 April 2021 in Molecules
Verified
Journal Article
Open access
PDF file
Marek KonopMarek Konop
Marek Konop
ALAnna Laskowska
Anna Laskowska
MRMateusz Rybka
Mateusz Rybka
Ewa KłodzińskaEwa Kłodzińska
Ewa Kłodzińska
DSDorota Sulejczak
Dorota Sulejczak
JCJoanna Czuwara
Joanna Czuwara
Impaired wound healing is a major medical challenge, especially in diabetics. Over the centuries, the main goal of tissue engineering and regenerative medicine has been to invent biomaterials that accelerate the wound healing process. In this context, keratin-derived biomaterial is a promising candidate due to its biocompatibility and biodegradability. In this study, we evaluated an insoluble fraction of keratin containing casomorphin as a wound dressing in a full-thickness surgical skin wound model in mice (n = 20) with iatrogenically induced diabetes. Casomorphin, an opioid peptide with analgesic properties, was incorporated into keratin and shown to be slowly released from the dressing. An in vitro study showed that keratin-casomorphin dressing is biocompatible, non-toxic, and supports cell growth. In vivo experiments demonstrated that keratin-casomorphin dressing significantly (p < 0.05) accelerates the whole process of skin wound healing to the its final stage. Wounds covered with keratin-casomorphin dressing underwent reepithelization faster, ending up with a thicker epidermis than control wounds, as confirmed by histopathological and immunohistochemical examinations. This investigated dressing stimulated macrophages infiltration, which favors tissue remodeling and regeneration, unlike in the control wounds in which neutrophils predominated. Additionally, in dressed wounds, the number of microhemorrhages was significantly decreased (p < 0.05) as compared with control wounds. The dressing was naturally incorporated into regenerating tissue during the wound healing process. Applied keratin dressing favored reconstruction of more regular skin structure and assured better cosmetic outcome in terms of scar formation and appearance. Our results have shown that insoluble keratin wound dressing containing casomorphin supports skin wound healing in diabetic mice.

25 October 2022 in Journal of Natural Fibers
Verified
Journal Article
Open access
Marek KonopMarek Konop
Marek Konop
MRMateusz Rybka
Mateusz Rybka
MSMateusz Szudzik
Mateusz Szudzik
ŁMŁukasz Mazurek
Łukasz Mazurek
ALAnna Laskowska
Anna Laskowska
JCJoanna Czuwara
Joanna Czuwara
Impaired wound healing particularly in diabetics creates a significant healthcare burden. The study aimed to evaluate the effect of keratin-butyrate fibers (FKDP +0.1%NaBu) in a full-thickness skin wound model in 30 diabetic rats. Physicochemical examination showed that the obtained dressing possesses a heterogeneous structure and butyrate was slowly released into the wound. Moreover, the obtained dressing is nontoxic and supports cell growth. In vivo results showed that keratin-butyrate dressing accelerated wound healing on days 4 and 7 post-injury (p < .05). Histopathological and immunofluorescence examination revealed that applied dressing stimulated macrophage infiltration, which favors tissue remodeling and regeneration. The dressing was naturally incorporated into regenerating tissue. The highest mRNA expression level of interleukin 1β (IL-1β) was observed during the first 2 weeks in the control wounds compared to FKDP +0.1%NaBu treated wounds, in which IL-1β was significantly decreased. In FKDP +0.1%NaBu dressed wounds, mRNA expression of IL-10 and VEGF increased significantly (p < .05) from day 14. Keratin-butyrate treated wounds enhanced mRNA expression of keratin 16 and 17 and zonula occludens protein-1 and junctional adhesion molecules (p < .05) on days 14, 21, and 28 post-injuries. Our study showed that keratin butyrate dressing is safe and can efficiently accelerate skin wound healing in diabetic rats. GRAPHIC ABSTRACT

5 December 2023 in Journal of Natural Fibers
Verified
Journal Article
Open access
MRMateusz Rybka
Mateusz Rybka
ŁMŁukasz Mazurek
Łukasz Mazurek
JCJoanna Czuwara
Joanna Czuwara
ALAnna Laskowska
Anna Laskowska
MSMateusz Szudzik
Mateusz Szudzik
Marek KonopMarek Konop
Marek Konop

23 October 2025 in Journal of Biomaterials Applications
Verified
Journal Article
Closed access
ICIthamar Cheyne
Ithamar Cheyne
MRMateusz Rybka
Mateusz Rybka
ŁMŁukasz Mazurek
Łukasz Mazurek
JJJan Jurak
Jan Jurak
Marek KonopMarek Konop
Marek Konop
The development of nanoparticle-based wound dressings marks a significant advancement in the management of chronic and non-healing wounds. Silver-based dressings have been used in wound management due to their strong antimicrobial properties. However, their clinical effectiveness depends on formulation, concentration, and duration of use. Recently, copper oxide dressings (CODs) have emerged as a novel alternative, offering both antimicrobial and regenerative benefits. We reviewed clinical studies, meta-analyses, and cost-effectiveness analyses on silver nanoparticle (AgNP), ionic silver, nanocrystalline silver, and copper oxide dressings across various wound types, including diabetic foot ulcers, venous leg ulcers, pressure ulcers, surgical wounds, and burns. Emphasis was placed on dressing formulations, silver or copper concentrations, clinical efficacy, safety, and cost-effectiveness. Traditional silver formulations, such as silver sulfadiazine (1%) and silver nitrate (0.5%), demonstrate antimicrobial activity but are limited by cytotoxicity and lack of long-term healing benefits. Nanocrystalline silver and ionic silver hydrofiber dressings provide sustained release, proving most effective in infection-prone and early inflammatory phases. Enhanced formulations (Aquacel® Ag + Extra™) show promise in treating biofilm-related wounds but need more robust data. By contrast, CODs have demonstrated antimicrobial efficacy alongside stimulation of angiogenesis, fibroblast proliferation, and extracellular matrix remodeling. Early clinical evidence suggests that CODs may accelerate healing in refractory wounds and offer cost advantages over negative pressure therapy, though large-scale trials remain limited. Silver dressings, particularly nanocrystalline and ionic hydrofiber formulations, remain clinically useful for infection control and short-term wound management, while older silver salts are less favorable due to toxicity and limited efficacy. CODs represent a biologically attractive alternative with dual antimicrobial and regenerative properties. Nonetheless, the current body of evidence is insufficient to declare a paradigm shift in wound healing, and CODs should presently be regarded as promising adjuncts pending validation in high-quality randomized trials.

Marek KonopMarek Konop
Marek Konop
MRMateusz Rybka
Mateusz Rybka
EWEmilia Waraksa
Emilia Waraksa
ALAnna Laskowska
Anna Laskowska
ANArtur Nowiński
Artur Nowiński
Ewa KłodzińskaEwa Kłodzińska
Ewa Kłodzińska
In competitive athletes, the differential diagnosis between nonpathological changes in cardiac morphology associated with training (commonly referred to as “athlete’s heart”) and certain cardiac diseases with the potential for sudden death is an important and not uncommon clinical problem. The use of noninvasive, fast, and cheap analytical techniques can help in making diagnostic differentiation and planning subsequent clinical strategies. Recent studies have demonstrated the role of gut microbiota and their metabolites in the onset and the development of cardiovascular diseases. Trimethylamine (TMA), a gut bacteria metabolite consisting of carnitine and choline, has recently emerged as a potentially toxic molecule to the circulatory system. The present work aims to develop a simple and cost-effective capillary electrophoresis-based method for the determination of TMA in biological samples. Analytical characteristics of the proposed method were evaluated through the study of its linearity (R2 > 0.9950) and the limit of detection and quantification (LOD = 1.2 µg/mL; LOQ = 3.6 µg/mL). The method shows great potential in high-throughput screening applications for TMA analysis in biological samples as a novel potential biomarker of cardiovascular diseases. The proposed electrophoretic method for the determination of TMA in biological samples from patients with cardiac disease is now in progress.